Mikko Rönty

2.0k citations

49 papers · 1.6k indexed · h-index 21

Impact in

Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Cancer Research top 10%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Pulmonary and Respiratory Medicine 32
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Occupational and environmental lung diseases 8
- Sarcoma Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
Molecular Biology 14
- TGF-β signaling in diseases 5

Co-authors: Olli Carpén (6 shared papers)Vuokko L. Kinnula (5 shared papers)Carol Otey (3 shared papers)Virinder Kaur Sarhadi (8 shared papers)Aija Knuuttila (8 shared papers)Irfan Rahman (1 shared paper)Marjukka Myllärniemi (11 shared papers)Wei Gu (1 shared paper)
Journals: Genes Chromosomes and Cancer (3 papers)Journal of Surgical Oncology (3 papers)Experimental Cell Research (3 papers)Lung (2 papers)Apmis (2 papers)
Partner nations: Finland United States United Kingdom

In The Last Decade

Mikko Rönty

49 papers receiving 1.5k citations

Peers

Countries citing papers authored by Mikko Rönty

Since Specialization

Citations

This map shows the geographic impact of Mikko Rönty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Rönty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Rönty more than expected).

Fields of papers citing papers by Mikko Rönty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Rönty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Rönty. The network helps show where Mikko Rönty may publish in the future.

Co-authors

The 25 scholars most cited alongside Mikko Rönty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mikko Rönty Line = papers co-authored together Mikko Rönty links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice Journal of Clinical Investigation ·Hongwei Yao, Sangwoon Chung, Jae‐Woong Hwang, R. Saravanan, Isaac K. Sundar, David A. Dean, Michael W. McBurney, Leonard Guarente, Wei Gu, Mikko Rönty, Vuokko L. Kinnula, Irfan Rahman	2012	296
2	Characterization of Human Palladin, a Microfilament-associated Protein Molecular Biology of the Cell ·Olli-Matti Mykkänen, Mikaela Grönholm, Mikko Rönty, Maciej Łałowski, Paula Salmikangas, Heli Suila, Olli Carpén	2001	129
3	Comparison of Targeted Next‐Generation Sequencing (NGS) and Real‐Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin‐Fixed, Paraffin‐Embedded Tumor Material of Non‐Small Cell Lung Carcinoma—Superiority of NGS Genes Chromosomes and Cancer ·Katja Tuononen, Satu Mäki‐Nevala, Virinder Kaur Sarhadi, Aino Wirtanen, Mikko Rönty, Kaisa Salmenkivi, J. M. Andrews, Aino Telaranta-Keerie, Sari Hannula, Sonja Lagström, Pekka Ellonen, Aija Knuuttila, Sakari Knuutila	2013	127
4	Molecular analysis of the interaction between palladin and α‐actinin FEBS Letters ·Mikko Rönty, Anu Taivainen, Monica Moza, Carol Otey, Olli Carpén	2004	74
5	Isoform-Specific Regulation of the Actin-Organizing Protein Palladin during TGF-β1-Induced Myofibroblast Differentiation Journal of Investigative Dermatology ·Mikko Rönty, Suvi-Katri Leivonen, Boris Hinz, Andrew Rachlin, Carol Otey, Veli‐Matti Kähäri, Olli Carpén	2006	72
6	Identification and Validation of Human Papillomavirus Encoded microRNAs PLoS ONE ·Kui Qian, Tuuli Pietilä, Mikko Rönty, Frédéric Michon, Mikko J. Frilander, Jarmo Ritari, Jussi Tarkkanen, Lars Paulín, Petri Auvinen, Eeva Auvinen	2013	63
7	Involvement of palladin and α-actinin in targeting of the Abl/Arg kinase adaptor ArgBP2 to the actin cytoskeleton Experimental Cell Research ·Mikko Rönty, Anu Taivainen, Monica Moza, Gary D. Kruh, Elisabeth Ehler, Olli Carpén	2005	56
8	Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease American Journal of Physiology-Lung Cellular and Molecular Physiology ·Steffen Ohlmeier, Pentti Nieminen, Jing Gao, Tinja Kanerva, Mikko Rönty, Tuula Toljamo, Ulrich Bergmann, Witold Mazur, Ville Pulkkinen	2016	43
9	Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo Scientific Reports ·Chang Li, Veronika Rezov, Emmi I. Joensuu, Ville Vartiainen, Mikko Rönty, Miao Yin, Marjukka Myllärniemi, Katri Koli	2018	42
10	Palladin interacts with SH3 domains of SPIN90 and Src and is required for Src-induced cytoskeletal remodeling Experimental Cell Research ·Mikko Rönty, Anu Taivainen, Leena Heiska, Carol Otey, Elisabeth Ehler, Woo Keun Song, Olli Carpén	2007	41
11	Targeted Resequencing RevealsALKFusions in Non-Small Cell Lung Carcinomas Detected by FISH, Immunohistochemistry, and Real-Time RT-PCR: A Comparison of Four Methods BioMed Research International ·Katja Tuononen, Virinder Kaur Sarhadi, Aino Wirtanen, Mikko Rönty, Kaisa Salmenkivi, Aija Knuuttila, Satu Maria Remes, Aino Telaranta-Keerie, Stuart Bloor, Pekka Ellonen, Sakari Knuutila	2013	41
12	Sputum Proteomics Identifies Elevated PIGR levels in Smokers and Mild-to-Moderate COPD Journal of Proteome Research ·Steffen Ohlmeier, Witold Mazur, Anna Linja-Aho, Noora Louhelainen, Mikko Rönty, Tuula Toljamo, Ulrich Bergmann, Vuokko L. Kinnula	2011	41
13	Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug Oncogenesis ·Jenni A. Tamminen, Ville Parviainen, Mikko Rönty, Alexander P. Wohl, Liisa Murray, Sakari Joenväärä, Markku Varjosalo, Outi Leppäranta, Olli Ritvos, Gerhard Sengle, Risto Renkonen, Marjukka Myllärniemi, K Koli	2013	36
14	The Histopathology of Idiopathic Pulmonary Fibrosis in West Highland White Terriers Shares Features of Both Non-specific Interstitial Pneumonia and Usual Interstitial Pneumonia in Man Journal of Comparative Pathology ·Pernilla Syrjä, Heikki Heikkilä, Liisa Lilja‐Maula, Émilie Krafft, Cécile Clercx, M.J. Day, Mikko Rönty, Marjukka Myllärniemi, Minna M. Rajamäki	2013	33
15	Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing Lung ·Satu Mäki‐Nevala, Virinder Kaur Sarhadi, Aija Knuuttila, Ilari Scheinin, Pekka Ellonen, Sonja Lagström, Mikko Rönty, Eeva Kettunen, Kirsti Husgafvel‐Pursiainen, Henrik Wolff, Sakari Knuutila	2015	32
16	Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma BMC Pulmonary Medicine ·Nobuhisa Ishikawa, Witold Mazur, Tuula Toljamo, Katri Vuopala, Mikko Rönty, Yasushi Horimasu, Nobuoki Kohno, Vuokko L. Kinnula	2011	28
17	Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma Oncotarget ·Miao Yin, Mira Tissari, Jenni A. Tamminen, Irene Ylivinkka, Mikko Rönty, Pernilla von Nandelstadh, Kaisa Lehti, Marko Hyytiäinen, Marjukka Myllärniemi, Katri Koli	2017	26
18	Radiotherapy in desmoid tumors Strahlentherapie und Onkologie ·Kirsi Santti, Annette Beule, Laura Tuomikoski, Mikko Rönty, Anna-Stina Jääskeläinen, Kauko Saarilahti, Hanna Ihalainen, Maija Tarkkanen, Carl Blomqvist	2017	25
19	Overexpression of activin-A and -B in malignant mesothelioma – Attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth Experimental Cell Research ·Jenni A. Tamminen, Miao Yin, Mikko Rönty, Eva Sutinen, Arja Pasternack, Olli Ritvos, Marjukka Myllärniemi, Katri Koli	2015	25
20	Driver Gene Mutations of Non-Small-Cell Lung Cancer are Rare in Primary Carcinoids of the Lung: NGS Study by Ion Torrent Lung ·Gemma Armengol, Virinder Kaur Sarhadi, Mikko Rönty, Milja Tikkanen, Aija Knuuttila, Sakari Knuutila	2015	23

About Mikko Rönty

Mikko Rönty is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cell Biology and Cancer Research, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (8 papers), Cellular Mechanics and Interactions (6 papers), Sarcoma Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (5 papers), TGF-β signaling in diseases (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). The work is most often cited by research in Geriatrics and Gerontology (98 citations), Cancer Research (303 citations), Pulmonary and Respiratory Medicine (596 citations), Immunology and Allergy (82 citations) and Cell Biology (200 citations). Mikko Rönty has collaborated with scholars based in Finland, United States and United Kingdom. Frequent co-authors include Olli Carpén, Vuokko L. Kinnula, Carol Otey, Virinder Kaur Sarhadi, Aija Knuuttila, Irfan Rahman, Marjukka Myllärniemi, Wei Gu, Leonard Guarente and Isaac K. Sundar. Their work appears in journals such as Genes Chromosomes and Cancer, Journal of Surgical Oncology, Experimental Cell Research, Lung and Apmis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact